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Background: Studies suggest an important role of autophagy as a target for cancer therapy. We constructed a
"disease-gene-drug" network using the modular approach of bioinformatics and screened herbal monomers
demonstrating functions related to autophagy regulation.
Methods: Based on the microarray results of the gene expression omnibus (GEO) database (GSE2435 and
GSE31040, starvation-induced autophagy model), we used the human protein reference database (HPRD) to obtain
the protein-protein interaction (PPI) network. In addition, we used the CFinder software to identify several functional
modules, performed gene ontology-biological process (GO-BP) functional enrichment analysis using the DAVID
software, constructed a herbal monomer-module gene regulatory network using literature search and the Cytoscape
software, and then analyzed the relationships between autophagy, genes, and herbal monomers.
Results: We screened 544 differentially expressed genes related to autophagy, 375 pairs of differentially expressed
genes, and 7 gene modules, wherein the functions of module 3 (composed of 7 genes) were enriched in "cell death".
Using the constructed herbal monomer-module gene regulatory network, we found that 30 herbal monomers can
simultaneously regulate these 7 genes, indicating a potential regulatory role in autophagy.
Conclusions: Database screening using the disease-gene-drug network can provide new strategies and ideas for the
application of herbal medicines in cancer therapy.
Keywords: Herbal monomer, Autophagy, Genomics, BioinformaticsBackground
For several thousands of years, natural products have
been used as medicines. Indeed, since ancient times,
humans have searched for naturally occurring sub-
stances to alleviate their sufferings. Before the invention
of synthetic drugs, natural drugs were the only choice
for treating diseases. Even today, many of the world's
populations still use natural medicine to treat diseases,
including traditional Chinese medicine. With the devel-
opment of science and technology, in-depth research has
been conducted on ancient drugs using modern approaches* Correspondence: Dongbo_xue@126.com; zhangweihui626@hotmail.com
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tures, and remarkable achievements have been made. Nat-
ural products are important sources of new anti-cancer
drugs, as more than 60% of anti-cancer drugs have been de-
rived from natural products. Recently, a significant number
of anti-cancer drugs derived from natural products, espe-
cially drugs of plant origins such as rhoeadine, podophyllo-
toxin, paclitaxel and camptothecin, have achieved great
success in clinical application [1,2].
Autophagy is an evolutionarily conserved process in-
volved in homeostasis by degrading organelles and pro-
teins to maintain biosynthesis during nutrient deprivation
or metabolic stress [3]. This process is important for
the elimination of damaged organelles and proteins
with long half-lives. Defect in autophagy is associatedis is an Open Access article distributed under the terms of the Creative
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age [4]. Loss of Beclin-1, an essential autophagy gene, is
present in 40-75% of solid tumors, suggesting a tumor
suppresion role of autophagy [4]. Although autophagy
has been identified as a type of programmed cell death
[5-7], autophagy is also a pro-survival process that en-
ables tumor cells to survive adverse conditions such as
hypoxia and chemotherapy [3,8]. Autophagy is a pathway
that is distinct from apoptosis, although some crosstalk ex-
ists between them [9,10]. Therefore, because autophagy
plays a complex and very important role in the pathogen-
esis and development of tumors, this process has become
an important anti-cancer therapy target. As a result, ap-
proaches to effectively regulate autophagy are increasingly
becoming the subject of active research.
In order to systematically identify herbal monomers
for potential application in tumor treatment with regards
to their ability to regulate autophagy, this study used the
approaches of modular bioinformatics analysis and net-
work pharmacology. Theoretically, if the inhibition of a
certain gene can affect the pathogenesis and develop-
ment of a disease, drugs regulating this gene might be
effective for its treatment. In addition, it has been noted
that disease occurrence is the result of changes in the
transcription of multiple genes or gene groups in the hu-
man genome. Therefore, drug treatment should also tar-
get the transcription of these genes or gene groups in
order to be more effective. Integrated analysis using "dis-
ease-gene" and “gene-drug" networks facilitate the iden-
tification of herbal monomers regulating autophagy,
providing novel uses for old drugs.
Methods
Microarray data processing
Two series of Earle’s balanced salt solution (EBSS)
starvation-induced autophagy model in a human lympho-
blastoid cell line were selected in this study, including
GSE2435 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE2345) [11] and GSE31040 (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc) [12], which can be obtained
from the GEO (Gene Expression Omnibus) database. The
differentially expressed genes were detected based on the
HG-U133-Plus-2 Affymetrix Human Genome U133 Plus
2.0 Array. Each experiment was repeated three times.
The microarray experiments performed in this study
included the controls and the autophagy conditions in
human cells, with three samples for each condition. We
downloaded the microarray CEL data compression pack-
age from the GEO supplementary file and extracted the
package to a folder for later use. We also downloaded
the raw data in TXT format. We used Bioconductor and
R 2.10.1 to normalize the downloaded data. A robust
multi-array average (RMA) algorithm was applied to cal-
culate the expression levels, and a multiscale adaptivesearch (MAS) algorithm was used to calculate the detec-
tion calls. Each group of samples with no less than 2 de-
tection calls was retained and called Present (P), in order
to filter low-expression probe sets. The HUGO Gene
Nomenclature Committee (HGNC) gene names for hu-
man genes were used to unify the gene names. We then
used the VLOOKUP function to replace the probe num-
bers in the original data and established the expression
data sheet containing the gene names and the corre-
sponding samples. We used the LIMMA differentially
expressed gene screen algorithm to screen genes either
upregulated or downregulated in the autophagy condi-
tion compared with the control condition, and the fold
of change, P-value and false discovery rate (FDR) were
calculated. P-values <0.5 or >2 indicated differentially
expressed genes.
The intersection between GSE2435 and GSE31040 was
used to screen the differentially expressed genes shared
by the two microarrays.Generation of differentially expressed gene modules and
functional analysis of the modules
We obtained the protein-protein interaction (PPI) net-
work from the Human Protein Reference Database
(HPRD). This network contains 36,874 edges and 9,453
nodes [13]. The differentially expressed genes were
mapped to the PPI network, and pairs in which the
two interacting proteins were both differentially
expressed were retained. Subsequently, sub-networks
were generated.
We used the CFinder software (http://cfinder.org/) to
identify functional modules in the sub-networks. CFin-
der [14] was used for finding and visualizing concealed
groups and modules in networks, based on the clique
percolation method (CPM). CFinder can find the full
join set of a specified size in the network and construct
larger node groups through the shared nodes and edges
in the full join set.
We used the Database for Annotation, Visualization
and Integrated Discovery (DAVID) software (v6.7) for
gene ontology-biological process (GO-BP) analysis of the
screened modules. We opened the DAVID database
(http://david.abcc.ncifcrf.gov/), submitted the gene groups
proposed for further analysis, checked the entire human
genome as the background genes, selected "Functional
Annotation Tool" as the analytical tool, and then ob-
tained the GO-BP enrichment analysis results (P-value
was 0.05).
A file of the interesting genes and their corresponding
GO-BP terms was generated. The file was imported to
Cytoscape (version 2.6.3) [15], the interaction type was
"default interaction", and the "layout", "cytoscape layout"
and "spring embedded" options were selected. At last, a
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was constructed.
Construction of the herbal monomer-module gene
regulatory networks
Based on the herbal monomer database (http://www.sepu.
net/html/article), we established a file of herbal monomers
including 30 monomers mightly related to autophagy, en-
tered the file of differentially expressed module genes and
the file of herbal monomers into the ActivePerl 5.16.2
software, and extracted a literature set from the PUBMED
database that was related to "each differentially expressed
module gene" and "each herbal monomer". We also con-
ducted preliminary grammar and syntax analyses of the
target literature set, analyzed the potential conceptual re-
lationship in the literature, and identified the correspond-
ing herbal monomers regulating target genes, followed by
manual screening. We then drew the herbal monomer-
module gene regulatory network diagram using the Cytos-
cape software (version 2.6.3).
Results
Detection of differentially expressed genes after
autophagy induction
GSE2435 detected a total of 13,234 genes. Taking a
P-value <0.05 as the significance level of differentially
expressed genes, we screened a total of 2783 differentially
expressed genes. GSE31040 detected a total of 14,442.
Taking a P-value <0.05 as the significance level for differ-
entially expressed genes, we screened a total of 2,369 dif-
ferentially expressed genes. There were a total of 544
differentially expressed genes identified for the intersec-
tion of GSE2435 and GSE31040.
Modular analysis results of autophagy-related genes
According to the HPRD database, there were a total of
36,875 PPI pairs. The differentially expressed genes were
then projected to the PPI pairs, and we ensured that
only the pairs in which the two interacting proteins were
both differentially expressed were retained. Eventually,
we obtained 375 differentially expressed relationship
pairs. We used the Cytoscape software to build the sub-
network diagram, and the results are shown in Figure 1.
The present study used the CFinder software to conduct
module identification for the differentially expressed PPI
pairs obtained from the steps described above. When
selecting k = 3, a total of 7 modules was obtained, as
shown in Figure 2.
We used the DAVID software to perform GO-BP
functional enrichment analysis for each of the 7 mod-
ules. The functional analysis results showed that the
functions enriched in module 3 were primarily related to
"cell death" (Figure 3). We thus chose module 3 as the
module of interest for further analysis.There seven genes within module 3, including NFKBIA,
GADD45A, GADD45B, CDKN1A, JUNB, PPP1R15A and
ATF3. We constructed the relationship diagram for each
gene and the corresponding GO-BP term using the Cytos-
cape software (Figure 4). The results indicated that
GADD45A, GADD45B, PPP1R15A and NFKBIA were
strongly related to "cell death".
Construction and analysis of gene-drug networks
The gene-drug network diagram of the seven genes in
module 3 and the herbal monomer library were con-
structed by literature mining (Figure 5). These results
showed that the effects of some herbal monomers were
multitargeted. Among them, 30 herbal monomers in
group E can act simultaneously on the 7 genes in mod-
ule 3, which were selected as the focus of our study.
Discussion
Programmed cell death is a spontaneous cell death
process committed to by cells with damage that cannot
be repaired, in order to maintain homeostasis. There are
three main types of programmed cell death: apoptosis,
autophagy and necrosis [3]. Autophagy itself is a mech-
anism by which abnormal intracellular components are
degraded to achieve homeostasis [3]. However, while
presenting increased autophagic activity, cell death in-
duced by many types of stress also shows morphological
characteristics that do not fully comply with apoptosis
or necrosis. Therefore, autophagy is considered a distinct
mechanism of cell death [9,10]. Autophagy plays an ex-
tremely important and complicated role in the patho-
genesis and development of tumors. Studies have
confirmed that autophagy is lower in tumor cells com-
pared with normal cells in the same tissue during the
early phase of tumorigenesis. Some tumors, such as liver
cancer caused by chemical carcinogens, already demon-
strate reduced autophagic capacity during the early
phase of tumorigenesis. However, some other cancers
(such as pancreatic cancer) showed increased autophagy
during tumorigenesis [16]. After tumor induction by car-
cinogens, rat pancreas cells demonstrated normal au-
tophagic capacity in precancerous nodules and adenomas,
whereas this level of autophagy was reduced upon the for-
mation of cancer cells [17]. Autophagy can first remove
organelles (primarily mitochondria) damaged by chemical
carcinogens, radiation and oxidative stress, thus avoiding
genetic instability due to DNA damage caused by reactive
oxygen species (ROS) and reducing the incidence of tu-
mors. In addition, autophagy can degrade the endoplasmic
reticulum, Golgi apparatus and other organelles, as well as
proteins with long half-lives. Therefore, pre-malignant
cells are in a negative balance of protein, which inhibits
uncontrolled proliferation [18]. Indeed, excessive autopha-
gic cell death can kill tumor cells, indicating the anti-
Figure 1 Sub-networks constructed from differentially expressed PPI pairs.
Figure 2 Modular analysis results using CFinder software (k = 3).
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Figure 3 GO-BP functional enrichment analyses of genes in module 3.
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duce autophagic cell death in MCF-7 cells [19], and ar-
senic trioxide can stimulate autophagy in lymphocytic
leukaemia and multiple myeloma cells [20]. After irradi-
ation, Bax−/−Bak−/− mouse embryonic fibroblast (MEF)
cells showed reduced Akt/mTOR signalling and increased
expression of ATG5, ATG12, Beclin1 and other autopha-
gic factors; moreover, after Rad001 (mTOR inhibitor)
treatment, autophagy was further enhanced, and MEF
cells presented autophagic cell death [21]. Therefore, stud-
ies focusing on the regulatory mechanisms of autophagy
and effective interventions for regulating autophagy have
become an active area of cancer treatment research.
In this study, we focused on autophagy regulation and
used microarray results from the GEO database to per-
form modular bioinformatics analysis using the CFinder,
DAVID and Cytoscape software. We screened a gene
group (module 3) composed of seven closely linked genes
among the differentially expressed genes after the induc-
tion of autophagy. The functions of this gene group wereFigure 4 Network diagrams of genes in module 3 and the correspond
triangle shape nodes indicate genes.primarily enriched in "cell death". In particular, four genes,
GADD45A, GADD45B, PPP1R15A and NFKBIA, were dir-
ectly related to "cell death".
NFKBIA (IkBα) encodes an inhibitor of NF-κB that
regulates the activity of NF-κB by binding to and dissoci-
ating from NF-κB [22]. Studies have shown that in acute
pancreatitis [23], the NF-κB signaling pathway regulates
the expression of microtubule-associated protein light chain
3 (LC3) and Beclin-l to regulate the occurrence of pancre-
atic autophagy in rat acute pancreatitis. Genetic changes in
NFKBIA are involved in colorectal [24] and glioblastoma
tumorigenesis [25].
The GADD45 family consists of three genes (GADD45A,
GADD45B and GADD45G) and have been shown to be in-
volved in tumorigenesis [26]. The common feature of the
GADD45 family is that the gene products can bind to the
N-terminal domain of MTK1 and activate the MTK1 kin-
ase and p38/JNK both in vivo and in vitro. It has also been
shown that p38 plays a decisive role in the regulation of
autophagy, and that SB203580 (a p38 specific inhibitor)ing GO-BP term. Ellipse shape nodes represent GO-BP terms, and
Figure 5 Network diagrams of the relationships between herbal monomers and genes in module 3. Ellipse shape nodes indicate herbal
monomers, and triangle shape nodes indicate genes.
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shown that JNK participates in CH11 (Fas agonistic anti-
body)-induced autophagy, and further experiments have
shown that the JNK inhibitor SP600125 can hinder the
process of autophagy [28], suggesting that JNK and p38 are
closely related to cellular autophagy. It can therefore be in-
ferred that the GADD45 family of genes are closely associ-
ated with autophagy.
CDKN1A, also known as p21, participates in cell cycle
regulation and inhibits or mediates apoptosis-related sig-
naling pathways [29]. It has also been reported that in
ceramide-treated MEFs, interference of p21 expression in
p21+/+ MEFs led to a decreased level of apoptosis and in-
creased autophagy, whereas p21 overexpression in p21−/−
MEFs enhanced autophagy and decreased the level of
apoptosis [30]. CDKN1A has been shown to be associated
with colorectal [31] and prostate cancer risk [32].
JUNB is also called Activator Protein 1 (AP-1) and is in-
volved in skin [33] and breast cancer development [34].
Recent studies have found that in the process of autoph-
agy, LC3 may bind specifically to the membrane structure
of trans-Golgi network (TGN), and then TGN generates
LC3-positive vesicles that bring LC3 to early autophago-
some structures formed by the endoplasmic reticulum or
other membrane structures [35]. In this process, the for-
mation of AP-1 was shown to regulate clathrin vesicles to-
gether with ATG9 to regulate autophagy through the
binding of LC3-PE to the corresponding complex and the
formation of LC3-positive vesicles.PPP1R15A (GADD34) dephosphorylates the eIF2α pro-
tein [36]. In MEFs, herpes simplex virus-induced PKR-
dependent eIF2α phosphorylation was shown to induce
autophagy. It has also been reported that eIF2α phosphor-
ylation is necessary for amino acid deficiency-induced au-
tophagy [37,38]. Thus, eIF2α phosphorylation plays an
important role in ER stress-induced autophagy.
From the above evidence, we can conclude that most
of the genes in module 3 are closely associated with au-
tophagy and that some of them are associated with can-
cer development. Because disease regulation by a single
gene is not efficient, we introduced the concept of net-
work pharmacology to examine how these genes are regu-
lated, established a gene-drug network based on previously
established disease-gene networks, and effectively com-
bined these approaches to derive drugs for the treatment
of diseases. The present study used the herbal monomer
database to screen for monomers targeting the 7 genes in
module 3. In particular, we performed literature mining
of the PUBMED database and constructed the herbal
monomer-module gene regulatory network using the
Cytoscape software. We then selected 30 herbal monomers
that could simultaneously act on these 7 genes and per-
formed further literature searches. We found that herbal
monomers such as resveratrol, curcumin, quercetin, and
melatonin showed important relationships with autophagy.
Resveratrol is a polyphenol compound extracted from
plants of the genus Vitis. Resveratrol possesses various
biological functions, such as the induction of cell cycle
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[39,40]. Yamamoto et al. [41] showed that resveratrol
could induce autophagy in glial cells; in addition, P38,
MAPK and ERK1/2 MAPK participate in resveratrol-
induced glial cell autophagy. Choi et al. [42] found that
resveratrol treatment could induce protective autophagy
in human dermal fibroblasts (HDFs) cultured under nor-
mal conditions. It has also been reported in the literature
[43] that resveratrol can induce autophagy in different
tumor cell lines including ovarian cancer [44,45], colorec-
tal cancer [46], gastric cancer [47], lung cancer and saliv-
ary gland cancer [48,49]. Many pathways and mechanisms
are involved in resveratrol-induced autophagy such as in-
hibition of the mTOR pathway and activation of the
MAPK pathway [44,50]. In addition, resveratrol-induced
autophagy stimulates an accumulation of PELP-1 (pro-
line-, glutamic acid-, and leucine-rich protein-1), which is
a class of estrogen receptor co-activator in autophago-
somes [49], as well as activation of Vps34 kinase and PI3K
[46]. Together, these findings show that resveratrol can in-
duce autophagy and may have an important role in tumor
therapy. However, resveratrol is mainly associated with
protective autophagy, and was identified in the present
study because we studied autophagy genes that were influ-
enced by herbal monomers.
Curcumin is a class of phenolic pigment extracted from
turmeric in the genus Curcuma and is a natural phenolic
antioxidant [51]. Turmeric roots contain a high content of
curcumin. Numerous in vivo and in vitro experiments
have shown that curcumin participates in the regulation
of multiple cellular pathways, such as NF-κB, AKT,
MAPK, p53, JAK/STAT and AMPK [52]. Related reports
have demonstrated that curcumin can inhibit the
growth of malignant glioma by inducing autophagy
[53]. Curcumin-induced autophagy can also reduce the
survival of cancer cells in hollow organs [54]. Li et al.
[55] found that, in SKN cells, curcumin induced au-
tophagy by activating the ERK1/2 pathway. In addition,
treatment with an ERK1/2 inhibitor could reduce the
ability of curcumin to induce autophagy and increase
the ability of curcumin to induce apoptosis. Yamauchi
et al. [56] reported that curcumin could increase LC3-II/
LC3-I expression, induce the formation of autophagosomes
and reduce ATG5 RNA silencing. Han et al. [57] found
that curcumin prevented oxidative stress-induced endothe-
lial cell damage by inducing autophagy. Together, these
findings confirm that curcumin has an important role in
the induction of autophagy.
Quercetin is a flavonoid antioxidant that is widely
present in plants. Wang et al. [58] experimentally con-
firmed that quercetin could induce gastric cancer cells
to form autophagic vacuoles, transform LC3-I into LC3-
II, and activate autophagy genes. In addition, Kim et al.
[59] found that quercetin could induce autophagy inU373MG cells, further confirming that quercetin initi-
ates the autophagy process in gastric cancer cells.
Melatonin is an indole compound that has important
physiological and pathological functions including regu-
lating the body's circadian rhythms and seasonal rhythms.
Choi et al. [60] found that in wild-type (WT) and GCD2-
homozygous (HO) corneal fibroblast cell lines, melatonin
could activate the initiation of autophagy. Recently, it was
also reported that melatonin could prevent ischemia-
reperfusion injury of the brain through the induction of
autophagy [61]. Chen et al. [62] further demonstrated that
melatonin could increase the LC3-II to LC3-I ratio and
enhance autophagy. Overall, these findings show that
melatonin plays an important role in the activation and
initiation of autophagy.
In addition to the drugs mentioned above and shown
to regulate autophagy, colchicine, patulin, chlorampheni-
col, genistein, L-arginine, benzo-(α)-pyrene and others
have been reported to induce apoptosis and may there-
fore demonstrate regulatory potential for autophagy. How-
ever, the exact effects of all these monomers on autophagy
and on the crosstalk between autophagy and apoptosis
need to be confirmed in vitro and in vivo. In addition, au-
tophagy may either promote cell survival or cell death, and
the delicate balance between the two is ill understood [8].
The present study revealed possible effects of some mono-
mers on genes involved in autophagy, but the results do
not allow determining if these monomers would tip the
balance one way or the other. Future studies are necessary
to address these issues.
Colchicine is an alkaloid extracted from the plant Col-
chicum autumnale in the lily family [63]. Chen et al.
[64] showed that colchicine could induce apoptosis
through the mitochondrial pathway in L-02 cells. Patulin
is a class of mycotoxin found in apples, grapes, pears and
peaches, andt is an effective genotoxic compound. Saxena
et al. [65] reported that patulin could induce DNA dam-
age, resulting in p53-mediated cell cycle arrest and sub-
sequent apoptosis. Kwon et al. [66] demonstrated that
patulin acts via oxidative stress to induce phosphorylation
of the transcription factor EGR-1 and thus increases the
expression of ATF3, leading to cell cycle arrest and activa-
tion of the apoptotic protein cascade. Taurine, also known
as β-aminoethanesulfonic acid, was first isolated from
calculus bovis. Taurine is chemically stable and is a
sulfur-containing non-protein amino acid that is closely
associated with human metabolism. Zhang et al. [67]
demonstrated that taurine could induce apoptosis in pul-
monary artery smooth muscle cells via the death-receptor
pathway. L-arginine is a semi-essential amino acid that
has nutritional and immune regulation functions, can act
as a precursor for the synthesis of nitric oxide, and is in-
volved in various physiological and pathological processes
in the body. Shu [68] found that L-arginine induces
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of the anti-apoptotic protein Bcl-2 and upregulating the
expression of the pro-apoptotic protein p53. Genistein is
an isoflavone found in soy and is a weak plant estrogen.
Recent studies from Xia et al. [69] found that genistein
could increase the expression of miR-34a, thereby inhibit-
ing the expression of Notch-1 and promoting apoptosis.
Kayisli et al. [70] demonstrated experimentally that genis-
tein acts as an anti-proliferative factor and can stimulate
human coronary artery endothelial cell apoptosis.
Therefore, some of the above-described herbal mono-
mers deduced from the disease-gene-drug network have
been shown to regulate the occurrence of autophagy,
thus confirming the validity of this method. Some other
herbal monomers deduced in this study have been used
in the study of apoptosis but have not been reported to
function in the regulation of autophagy, suggesting that
we may find new drugs that can regulate autophagy
among these herbal monomers.
The present study suffers from some limitations. In-
deed, the aim of the present study was to use a new ap-
proach to screen for herbal monomers that could influence
autophagy genes. However, each of these monomers will
have to be carefully studied to determine their exact effects
in vitro and in vivo and which way they normally tip au-
tophagy (cell survival or death), and if the balance could be
tipped the other way in specific circumstances. In addition,
there is crosstalk between autophagy and apoptosis [9,10],
and future studies should evaluate the effects of different
compounds on this crosstalk.
Conclusion
This study provides a new strategy to discover herbal
compounds for tumor treatment and disease alleviation
that may assist with the identification of tumor cell au-
tophagy inducers in the future.
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